The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Syndromic Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2029
Synopsis
The global Syndromic Testing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Syndromic testing is the process of using one test to simultaneously target multiple pathogens with overlapping signs and symptoms.Syndromic testing is a type of testing used in medical diagnosis that looks for multiple different infectious agents at the same time, often based on the symptoms and signs exhibited by the patient. This type of testing is usually performed when a patient presents with symptoms that are difficult to diagnose or when there is a suspected outbreak of an infectious disease.Syndromic testing is a useful tool in the diagnosis and management of infectious diseases.
This report is a detailed and comprehensive analysis for global Syndromic Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Syndromic Testing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Syndromic Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Syndromic Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Syndromic Testing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Syndromic Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Syndromic Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Qiagen, Abbott Diagnostics, Vela Diagnostics and Veramarx, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Syndromic Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Respiratory Infections
Sexually Transmitted Infections (STIs)
Gastrointestinal Infections
Central Nervous System Infections
Others
Market segment by Application
Outbreak Response
Emergency Departments
Travel Medicine
Military Medicine
Public Health Surveillance
Market segment by players, this report covers
Thermo Fisher Scientific Inc.
Qiagen
Abbott Diagnostics
Vela Diagnostics
Veramarx
Visby Medical
XCR Diagnostics
Beckman Coulter Diagnostics
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc
Bosch Healthcare Solutions GmbH
Genetic Signatures
GenMark Dx (Roche)
Hologic
Roche Molecular Diagnostics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Syndromic Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Syndromic Testing, with revenue, gross margin and global market share of Syndromic Testing from 2018 to 2023.
Chapter 3, the Syndromic Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Syndromic Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Syndromic Testing.
Chapter 13, to describe Syndromic Testing research findings and conclusion.
The global Syndromic Testing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Syndromic testing is the process of using one test to simultaneously target multiple pathogens with overlapping signs and symptoms.Syndromic testing is a type of testing used in medical diagnosis that looks for multiple different infectious agents at the same time, often based on the symptoms and signs exhibited by the patient. This type of testing is usually performed when a patient presents with symptoms that are difficult to diagnose or when there is a suspected outbreak of an infectious disease.Syndromic testing is a useful tool in the diagnosis and management of infectious diseases.
This report is a detailed and comprehensive analysis for global Syndromic Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Syndromic Testing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Syndromic Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Syndromic Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Syndromic Testing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Syndromic Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Syndromic Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Qiagen, Abbott Diagnostics, Vela Diagnostics and Veramarx, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Syndromic Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Respiratory Infections
Sexually Transmitted Infections (STIs)
Gastrointestinal Infections
Central Nervous System Infections
Others
Market segment by Application
Outbreak Response
Emergency Departments
Travel Medicine
Military Medicine
Public Health Surveillance
Market segment by players, this report covers
Thermo Fisher Scientific Inc.
Qiagen
Abbott Diagnostics
Vela Diagnostics
Veramarx
Visby Medical
XCR Diagnostics
Beckman Coulter Diagnostics
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc
Bosch Healthcare Solutions GmbH
Genetic Signatures
GenMark Dx (Roche)
Hologic
Roche Molecular Diagnostics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Syndromic Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Syndromic Testing, with revenue, gross margin and global market share of Syndromic Testing from 2018 to 2023.
Chapter 3, the Syndromic Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Syndromic Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Syndromic Testing.
Chapter 13, to describe Syndromic Testing research findings and conclusion.
Index1 Market Overview
1.1 Product Overview and Scope of Syndromic Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Syndromic Testing by Type
1.3.1 Overview: Global Syndromic Testing Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Syndromic Testing Consumption Value Market Share by Type in 2022
1.3.3 Respiratory Infections
1.3.4 Sexually Transmitted Infections (STIs)
1.3.5 Gastrointestinal Infections
1.3.6 Central Nervous System Infections
1.3.7 Others
1.4 Global Syndromic Testing Market by Application
1.4.1 Overview: Global Syndromic Testing Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Outbreak Response
1.4.3 Emergency Departments
1.4.4 Travel Medicine
1.4.5 Military Medicine
1.4.6 Public Health Surveillance
1.5 Global Syndromic Testing Market Size & Forecast
1.6 Global Syndromic Testing Market Size and Forecast by Region
1.6.1 Global Syndromic Testing Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Syndromic Testing Market Size by Region, (2018-2029)
1.6.3 North America Syndromic Testing Market Size and Prospect (2018-2029)
1.6.4 Europe Syndromic Testing Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Syndromic Testing Market Size and Prospect (2018-2029)
1.6.6 South America Syndromic Testing Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Syndromic Testing Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Thermo Fisher Scientific Inc.
2.1.1 Thermo Fisher Scientific Inc. Details
2.1.2 Thermo Fisher Scientific Inc. Major Business
2.1.3 Thermo Fisher Scientific Inc. Syndromic Testing Product and Solutions
2.1.4 Thermo Fisher Scientific Inc. Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.2 Qiagen
2.2.1 Qiagen Details
2.2.2 Qiagen Major Business
2.2.3 Qiagen Syndromic Testing Product and Solutions
2.2.4 Qiagen Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Qiagen Recent Developments and Future Plans
2.3 Abbott Diagnostics
2.3.1 Abbott Diagnostics Details
2.3.2 Abbott Diagnostics Major Business
2.3.3 Abbott Diagnostics Syndromic Testing Product and Solutions
2.3.4 Abbott Diagnostics Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Abbott Diagnostics Recent Developments and Future Plans
2.4 Vela Diagnostics
2.4.1 Vela Diagnostics Details
2.4.2 Vela Diagnostics Major Business
2.4.3 Vela Diagnostics Syndromic Testing Product and Solutions
2.4.4 Vela Diagnostics Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Vela Diagnostics Recent Developments and Future Plans
2.5 Veramarx
2.5.1 Veramarx Details
2.5.2 Veramarx Major Business
2.5.3 Veramarx Syndromic Testing Product and Solutions
2.5.4 Veramarx Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Veramarx Recent Developments and Future Plans
2.6 Visby Medical
2.6.1 Visby Medical Details
2.6.2 Visby Medical Major Business
2.6.3 Visby Medical Syndromic Testing Product and Solutions
2.6.4 Visby Medical Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Visby Medical Recent Developments and Future Plans
2.7 XCR Diagnostics
2.7.1 XCR Diagnostics Details
2.7.2 XCR Diagnostics Major Business
2.7.3 XCR Diagnostics Syndromic Testing Product and Solutions
2.7.4 XCR Diagnostics Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 XCR Diagnostics Recent Developments and Future Plans
2.8 Beckman Coulter Diagnostics
2.8.1 Beckman Coulter Diagnostics Details
2.8.2 Beckman Coulter Diagnostics Major Business
2.8.3 Beckman Coulter Diagnostics Syndromic Testing Product and Solutions
2.8.4 Beckman Coulter Diagnostics Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Beckman Coulter Diagnostics Recent Developments and Future Plans
2.9 Becton, Dickinson and Company
2.9.1 Becton, Dickinson and Company Details
2.9.2 Becton, Dickinson and Company Major Business
2.9.3 Becton, Dickinson and Company Syndromic Testing Product and Solutions
2.9.4 Becton, Dickinson and Company Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Becton, Dickinson and Company Recent Developments and Future Plans
2.10 Bio-Rad Laboratories, Inc
2.10.1 Bio-Rad Laboratories, Inc Details
2.10.2 Bio-Rad Laboratories, Inc Major Business
2.10.3 Bio-Rad Laboratories, Inc Syndromic Testing Product and Solutions
2.10.4 Bio-Rad Laboratories, Inc Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Bio-Rad Laboratories, Inc Recent Developments and Future Plans
2.11 Bosch Healthcare Solutions GmbH
2.11.1 Bosch Healthcare Solutions GmbH Details
2.11.2 Bosch Healthcare Solutions GmbH Major Business
2.11.3 Bosch Healthcare Solutions GmbH Syndromic Testing Product and Solutions
2.11.4 Bosch Healthcare Solutions GmbH Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Bosch Healthcare Solutions GmbH Recent Developments and Future Plans
2.12 Genetic Signatures
2.12.1 Genetic Signatures Details
2.12.2 Genetic Signatures Major Business
2.12.3 Genetic Signatures Syndromic Testing Product and Solutions
2.12.4 Genetic Signatures Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Genetic Signatures Recent Developments and Future Plans
2.13 GenMark Dx (Roche)
2.13.1 GenMark Dx (Roche) Details
2.13.2 GenMark Dx (Roche) Major Business
2.13.3 GenMark Dx (Roche) Syndromic Testing Product and Solutions
2.13.4 GenMark Dx (Roche) Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 GenMark Dx (Roche) Recent Developments and Future Plans
2.14 Hologic
2.14.1 Hologic Details
2.14.2 Hologic Major Business
2.14.3 Hologic Syndromic Testing Product and Solutions
2.14.4 Hologic Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Hologic Recent Developments and Future Plans
2.15 Roche Molecular Diagnostics
2.15.1 Roche Molecular Diagnostics Details
2.15.2 Roche Molecular Diagnostics Major Business
2.15.3 Roche Molecular Diagnostics Syndromic Testing Product and Solutions
2.15.4 Roche Molecular Diagnostics Syndromic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Roche Molecular Diagnostics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Syndromic Testing Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Syndromic Testing by Company Revenue
3.2.2 Top 3 Syndromic Testing Players Market Share in 2022
3.2.3 Top 6 Syndromic Testing Players Market Share in 2022
3.3 Syndromic Testing Market: Overall Company Footprint Analysis
3.3.1 Syndromic Testing Market: Region Footprint
3.3.2 Syndromic Testing Market: Company Product Type Footprint
3.3.3 Syndromic Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Syndromic Testing Consumption Value and Market Share by Type (2018-2023)
4.2 Global Syndromic Testing Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Syndromic Testing Consumption Value Market Share by Application (2018-2023)
5.2 Global Syndromic Testing Market Forecast by Application (2024-2029)
6 North America
6.1 North America Syndromic Testing Consumption Value by Type (2018-2029)
6.2 North America Syndromic Testing Consumption Value by Application (2018-2029)
6.3 North America Syndromic Testing Market Size by Country
6.3.1 North America Syndromic Testing Consumption Value by Country (2018-2029)
6.3.2 United States Syndromic Testing Market Size and Forecast (2018-2029)
6.3.3 Canada Syndromic Testing Market Size and Forecast (2018-2029)
6.3.4 Mexico Syndromic Testing Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Syndromic Testing Consumption Value by Type (2018-2029)
7.2 Europe Syndromic Testing Consumption Value by Application (2018-2029)
7.3 Europe Syndromic Testing Market Size by Country
7.3.1 Europe Syndromic Testing Consumption Value by Country (2018-2029)
7.3.2 Germany Syndromic Testing Market Size and Forecast (2018-2029)
7.3.3 France Syndromic Testing Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Syndromic Testing Market Size and Forecast (2018-2029)
7.3.5 Russia Syndromic Testing Market Size and Forecast (2018-2029)
7.3.6 Italy Syndromic Testing Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Syndromic Testing Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Syndromic Testing Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Syndromic Testing Market Size by Region
8.3.1 Asia-Pacific Syndromic Testing Consumption Value by Region (2018-2029)
8.3.2 China Syndromic Testing Market Size and Forecast (2018-2029)
8.3.3 Japan Syndromic Testing Market Size and Forecast (2018-2029)
8.3.4 South Korea Syndromic Testing Market Size and Forecast (2018-2029)
8.3.5 India Syndromic Testing Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Syndromic Testing Market Size and Forecast (2018-2029)
8.3.7 Australia Syndromic Testing Market Size and Forecast (2018-2029)
9 South America
9.1 South America Syndromic Testing Consumption Value by Type (2018-2029)
9.2 South America Syndromic Testing Consumption Value by Application (2018-2029)
9.3 South America Syndromic Testing Market Size by Country
9.3.1 South America Syndromic Testing Consumption Value by Country (2018-2029)
9.3.2 Brazil Syndromic Testing Market Size and Forecast (2018-2029)
9.3.3 Argentina Syndromic Testing Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Syndromic Testing Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Syndromic Testing Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Syndromic Testing Market Size by Country
10.3.1 Middle East & Africa Syndromic Testing Consumption Value by Country (2018-2029)
10.3.2 Turkey Syndromic Testing Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Syndromic Testing Market Size and Forecast (2018-2029)
10.3.4 UAE Syndromic Testing Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Syndromic Testing Market Drivers
11.2 Syndromic Testing Market Restraints
11.3 Syndromic Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Syndromic Testing Industry Chain
12.2 Syndromic Testing Upstream Analysis
12.3 Syndromic Testing Midstream Analysis
12.4 Syndromic Testing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
